Gentamicin Injection, Solution
Product Images NDC 51662-1508

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Gentamicin (NDC 51662-1508). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Vial Label (51662 1508 2 Vial Label)

Label for GENTAMICIN injection USP 40 mg/mL, a sterile solution for intramuscular or intravenous use. This 20 mL multiple dose vial is manufactured by APP Pharmaceuticals, LLC and labeled for prescription use only. The label includes ingredient and preservative details, storage instructions at 20° to 25°C, and a barcode with NDC 63323-010-20.*

FDA Label Image

Pouch Labeling (51662 1508 2 Hf Pouch Label Image)

Label for Gentamicin Injection, USP 800 mg/20 mL (40 mg/mL) 20 mL vial. The label includes NDC 51662-1508-2, lot number 123456, and expiration date 2030-01-01. It indicates the product is for intramuscular or intravenous use, must be diluted for IV use, and is sterile. Manufactured by HF Acquisition Co LLC, Mukilteo, WA.*

FDA Label Image

Box Label (51662 1508 3 Case Label)

Label for GENTAMICIN injection USP 800 mg/20 mL (40 mg/mL) in a 20 mL vial, packaged as a box of 25. The label includes the NDC 51662-1508-3 and indicates the drug is for intramuscular or intravenous use, requiring dilution for IV use. Manufactured by HF Acquisition Co., LLC, Mukilteo, WA.*

FDA Label Image

Serialized Label (51662 1508 3 Serialized Label)

A small white label featuring a Data Matrix barcode and multiple strings of numeric codes. Text indicates distribution by HF Acquisition Co., LLC in Mukilteo, WA 98275 and advises to see the manufacturer's package insert. The right edge has vertical text reading 'RX ONLY'. The image does not show the product name, strength, dosage form, or other identifying drug information.*

FDA Label Image

Boxed Warning (Boxed Warning)

A boxed warning text panel detailing the risks and precautions associated with aminoglycoside use, specifically gentamicin injection. It covers potential nephrotoxicity, neurotoxicity, monitoring recommendations for renal function and serum drug levels, and warnings about use during pregnancy and with certain other medications. The text emphasizes careful clinical observation and dosage adjustments to avoid toxicity.*

FDA Label Image

C1 (Clinical 1)

A susceptibility interpretive criteria table listing three pathogens: Enterobacteriaceae, Pseudomonas aeruginosa, and Staphylococcus Species. It shows minimal inhibitory concentration (mcg/mL) breakpoints for susceptible (≤4), intermediate (8), and resistant (≥16), and zone diameter breakpoints (mm) for susceptible (≥15), intermediate (13 to 14), and resistant (≤12).*

FDA Label Image

C2 (Clinical 2)

Data table listing quality control organisms with their minimum inhibitory concentrations (mcg/mL) and corresponding zone diameters (mm), including organisms such as Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, and Enterococcus faecalis.*

FDA Label Image

D And A 1 (D And A 1)

Dosage schedule guide table for Gentamicin injection solution 40 mg/mL for adults with normal renal function, showing patient weight in kg and lbs, usual dose for serious infections (mg/dose and mL/dose at 1 mg/kg q8h or 5 mg/kg/day), and dose for life-threatening infections (mg/dose and mL/dose at 1.7 mg/kg q8h or 5 mg/kg/day). The table includes doses at 8-hour intervals for weights from 40 to 100 kg, with notes on dosage adjustments for obese patients and q8h schedule recalculation.*

FDA Label Image

D And A 2 (D And A 2)

A dosage adjustment guide table for patients with renal impairment related to gentamicin. The table lists serum creatinine levels (mg %), approximate creatinine clearance rates (mL/min/1.73m²), and the corresponding percent of usual gentamicin doses to administer at eight-hour intervals after the usual initial dose.*

FDA Label Image

Hs1 (How Supplied)

A data table listing product codes, units of sale, strengths, and package details for Gentamicin injection solution. It shows two entries: one with code 1002 for 2 mL multiple dose vial at 40 mg/mL strength, and another with code 1020 for 20 mL multiple dose vial at the same strength.*

FDA Label Image

Logo (Logo)

FDA Label Image

Structure (Structure)

Chemical structure of gentamicin including its sulfate form and variations in the R group labeled as C1, C2, and C1A. The diagram shows detailed molecular components of gentamicin.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.